FDA rejects Capricor’s cell therapy for Duchenne muscular dystrophy The decision follows the ouster of the agency’s chief regulator of cell and gene therapies

https://www.statnews.com/2025/07/11/fda-rejects-capricors-cell-therapy-for-duchenne-muscular-dystrophy/